HCP (HCP) : During the past 4 weeks, traders have been relatively bearish on HCP (HCP), hence the stock is down -3.91% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -3.06% relative to the S&P 500. The 4-week change in the price of the stock is -5.85% and the stock has fallen -2.54% in the past 1 week.
The stock has recorded a 20-day Moving Average of 4.63% and the 50-Day Moving Average is 3.11%.The 200 Day SMA reached 8.25% HCP, Inc. is up 7.21% in the last 3-month period. Year-to-Date the stock performance stands at 1.85%.
HCP (HCP) : The consensus price target for HCP (HCP) is $35.57 for the short term with a standard deviation of $3.99. The most optimist securities analyst among the 7 who monitor the stock believes that the stock can reach $43, however, the pessimist price target for the company is $32.
Company shares have received an average consensus rating of Hold for the current week HCP (NYSE:HCP): The stock opened at $36.88 and touched an intraday high of $37.22 on Friday. During the day, the stock corrected to an intraday low of $36.65, however, the bulls stepped in and pushed the price higher to close in the green at $37.16 with a gain of 0.35% for the day. The total traded volume for the day was 4,296,804. The stock had closed at $37.03 in the previous trading session.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.